Fragment-based screening of programmed death ligand 1 (PD-L1) - ScienceDirect
Fragment-based screening of programmed death ligand 1 (PD-L1) - ScienceDirect
Programmed cell death-1/programmed cell death ligand-1 checkpoint inhibitors: differences in mechanism of action | Immunotherapy
Cancers | Free Full-Text | Long Non-Coding RNAs: Tools for Understanding and Targeting Cancer Pathways
Discordance of PD-L1 status between primary and metastatic breast cancer: A systematic review and meta-analysis - Cancer Treatment Reviews
IJMS | Free Full-Text | Programmed Death Ligand 1 Indicates Pre-Existing Adaptive Immune Response by Tumor-Infiltrating CD8+ T Cells in Non-Small Cell Lung Cancer
Reconstruction of the Fas-Based Death-Inducing Signaling Complex (DISC) Using a Protein–Protein Docking Meta-Approach | Journal of Chemical Information and Modeling
Programmed Death-Ligand 1 and Programmed Death-Ligand 2 mRNAs Measured Using Closed-System Quantitative Real-Time Polymerase Chain Reaction Are Associated With Outcome and High Negative Predictive Value in Immunotherapy-Treated NSCLC - ScienceDirect
Nutrients | Free Full-Text | The Effects of Omega-3 Polyunsaturated Fatty Acids on Breast Cancer as a Preventive Measure or as an Adjunct to Conventional Treatments
Mechanism of anti-programmed death 1 (PD-1) receptor and... | Download Scientific Diagram
Programmed cell death-1 and programmed cell death ligand-1 antibodies-induced dysthyroidism in: Endocrine Connections Volume 7 Issue 5 (2018)
Programmed death‑ligand 1 positivity can predict improved survival and a lower risk of brain metastasis in patients with resectable small cell lung cancer
The immune checkpoint B7-H3 (CD276) regulates adipocyte progenitor metabolism and obesity development | Science Advances
IJMS | Free Full-Text | Tumors of the Nose and Paranasal Sinuses: Promoting Factors and Molecular Mechanisms—A Systematic Review
PD-1/PD-L1 checkpoint blockade harnesses monocyte-derived macrophages to combat cognitive impairment in a tauopathy mouse model | Nature Communications
Programmed Death-Ligand 1 and Programmed Death-Ligand 2 mRNAs Measured Using Closed-System Quantitative Real-Time Polymerase Chain Reaction Are Associated With Outcome and High Negative Predictive Value in Immunotherapy-Treated NSCLC - ScienceDirect
Cancers | Free Full-Text | Programmed Death-Ligand 1 (PD-L1) as Immunotherapy Biomarker in Breast Cancer
Programmed Death-Ligand 1 Heterogeneity and Its Impact on Benefit From Immune Checkpoint Inhibitors in NSCLC - ScienceDirect
Representative programmed cell death-ligand 1 (PD-L1) and... | Download Scientific Diagram
Programmed cell death protein receptor and ligands in haematological malignancies – Current status - ScienceDirect
IJMS | Free Full-Text | Programmed Death Ligand 1 Indicates Pre-Existing Adaptive Immune Response by Tumor-Infiltrating CD8+ T Cells in Non-Small Cell Lung Cancer
Structural insights and binding analysis for determining the molecular bases for programmed cell death protein ligand-1 inhibition - MedChemComm (RSC Publishing)
Programmed cell death-1/programmed cell death ligand-1 checkpoint inhibitors: differences in mechanism of action | Immunotherapy
Programmed death-1 receptor (PD-1) and PD-ligand-1 (PD-L1) expression in non-small cell lung cancer and the immune-suppressive effect of anaerobic glycolysis | SpringerLink
In situ and in silico kinetic analyses of programmed cell death-1 (PD-1) receptor, programmed cell death ligands, and B7-1 protein interaction network - Journal of Biological Chemistry
Programmed Death-Ligand 1 and Programmed Death-Ligand 2 mRNAs Measured Using Closed-System Quantitative Real-Time Polymerase Chain Reaction Are Associated With Outcome and High Negative Predictive Value in Immunotherapy-Treated NSCLC - ScienceDirect
PLGA Nanoparticles Codelivering siRNAs against Programmed Cell Death Protein-1 and Its Ligand Gene for Suppression of Colon Tumor Growth.,Molecular Pharmaceutics - X-MOL
